83 related articles for article (PubMed ID: 8965940)
1. [Prenatal study of trisomy 21: triple test more efficient than age criterion].
Mul NA; ten Velden GH
Ned Tijdschr Geneeskd; 1996 Oct; 140(41):2032-5. PubMed ID: 8965940
[TBL] [Abstract][Full Text] [Related]
2. Major decrease in the incidence of trisomy 21 at birth in south Belgium: mass impact of triple test?
Verloes A; Gillerot Y; Van Maldergem L; Schoos R; Herens C; Jamar M; Dideberg V; Lesenfants S; Koulischer L
Eur J Hum Genet; 2001 Jan; 9(1):1-4. PubMed ID: 11175292
[TBL] [Abstract][Full Text] [Related]
3. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
Biggio JR; Morris TC; Owen J; Stringer JS
Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
[TBL] [Abstract][Full Text] [Related]
4. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
5. [Prenatal studies of trisomy 21: triple test more efficient than age criterion].
Drenthe-Schonk A
Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2477. PubMed ID: 8999352
[No Abstract] [Full Text] [Related]
6. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
7. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
8. [Down syndrome in the northeastern Netherlands; expectations and reality 1981-1986].
Cornel MC; Tuerlings JH; Breed AS; ten Kate LP
Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1852-5. PubMed ID: 2145518
[TBL] [Abstract][Full Text] [Related]
9. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
Thix J
Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
[TBL] [Abstract][Full Text] [Related]
10. Sequential pathways of testing after first-trimester screening for trisomy 21.
Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
[TBL] [Abstract][Full Text] [Related]
11. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
[TBL] [Abstract][Full Text] [Related]
12. [Trisomy 21 and its prenatal detection in the Canton of Vaud (1980-1996)].
Pescia G; Addor MC
Schweiz Med Wochenschr; 2000 Sep; 130(38):1332-8. PubMed ID: 11064925
[TBL] [Abstract][Full Text] [Related]
13. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of trisomy 18 screening using the second-trimester triple test.
Meier C; Huang T; Wyatt PR; Summers AM
Prenat Diagn; 2003 Jun; 23(6):443-6. PubMed ID: 12813756
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.
Nicolaides KH; Chervenak FA; McCullough LB; Avgidou K; Papageorghiou A
Am J Obstet Gynecol; 2005 Aug; 193(2):322-6. PubMed ID: 16098850
[TBL] [Abstract][Full Text] [Related]
16. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
[TBL] [Abstract][Full Text] [Related]
17. [Importance of AFPplus-screening in daily practice. Evaluation of 2641 analyses].
Longoni S; Ackermann M; Viollier EH
Praxis (Bern 1994); 1997 Apr; 86(18):741-7. PubMed ID: 9244963
[TBL] [Abstract][Full Text] [Related]
18. [Prenatal diagnosis for trisomy 21: triple test more efficient than age criterion].
Beekhuis JR; Mantingh A
Ned Tijdschr Geneeskd; 1997 Jan; 141(1):63. PubMed ID: 9162857
[No Abstract] [Full Text] [Related]
19. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
20. [Maternal serum screening for Down syndrome and neural tube defects].
van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
